A study to know the effect of haridradi drug paste in external sweelings

A randomized controlled clinical study to evaluate the efficacy of haridradi lepa in the managment of agantuja shopha (superficial thrombophlebitis) - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090050

Enrollment

Registered

2025-07-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I808- Phlebitis and thrombophlebitis ofother sites

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Clinical signs and symptom of Superficial Venous Thrombophlebitis 2)Established cases of Superficial Venous Thrombosis due to IV canulization in upper limbs

Exclusion criteria

Exclusion criteria: 1)HIV and HbsAg positive patients 2)Cases of Deep Vein Thrombosis 3)Subjects under immunosuppresants 4)Patients on anti-coagulants bleeding disorders (thrombocytopenia hemophilia) 5) Uncontrolled Diabetic Mellitus(greater than250mg per dl)

Design outcomes

Primary

Measure	Time frame
reduction of pain tenderness swelling and local raised temperature and after application of haridradi lepaTimepoint: 21 days	—

Secondary

Measure	Time frame
thrombophob ointment is more effective than haridradi lepaTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDrLohit kalal

Shree jagadguru gavisiddeshwara ayurvedic medical college and hospital koppal

dr.lohitkalal7108@gmail.com7090116108

Outcome results